We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
GLOBETECH PUBLISHING LLC

Download Mobile App




Advanced Ultrasound Technology Helps Drive First-Stick Success for IV Insertions

By MedImaging International staff writers
Posted on 12 Apr 2023
Image: BD Prevue II system uses connected ultrasound technology to drive more intuitive IV placement and control (Photo courtesy of BD)
Image: BD Prevue II system uses connected ultrasound technology to drive more intuitive IV placement and control (Photo courtesy of BD)

A majority of hospitalized patients, over 90%, receive IV therapy through a peripheral IV catheter, accounting for hundreds of millions of patients annually. However, around two-thirds of these patients have veins that are challenging to visualize and access, leading to multiple needlesticks, vessel damage, and infiltration into surrounding tissue. Studies suggest that combining a needle-tracking system with ultrasound guidance may decrease the number of attempts and time needed for successful vessel access, potentially making vascular access procedures safer and more straightforward for both clinicians and patients. Now, a new advanced ultrasound device, featuring a specialized probe, has been developed to aid clinicians in achieving optimal IV placement.

The BD Prevue II System from Becton, Dickinson and Company (BD, Franklin Lakes, NJ, USA) offers real-time needle depth markers, addressing a critical need in IV access. The system includes the BD Cue Needle Tracking System, which provides a high-quality ultrasound image of the needle's trajectory, and is compatible with BD Cue Needle Tracking-enabled catheters. The system's clinician-friendly features aim to broaden the use of ultrasound in IV placement. For instance, the BD Prevue II System's specialized probe is designed to minimize the learning curve, enabling clinicians to use the technology without altering their current insertion techniques or field of view.

The BD Prevue II System supports BD's "One-Stick Hospital Stay" vision, which aims to reduce unnecessary needlesticks by selecting the appropriate vascular access device and successfully placing it on the first try. This vision encompasses three key aspects: using one IV line as a single access point for required therapies and blood draws, maintaining the IV line optimally to reduce the risk of complications, and ensuring the IV line does not need to be replaced and lasts throughout a patient's hospital stay.

"Difficult IV access remains far too common today, but the availability of the BD Prevue II System supports a future where every needlestick has a predefined pathway for successful placement," said Eric Borin, worldwide president of Medication Delivery Solutions at BD. "BD is advancing the vision of a 'One-Stick Hospital Stay,' and first-stick success is the first requirement to fulfill that vision. First-stick success also reduces the pain and anxiety patients often experience while undergoing multiple IV access attempts and provides clinicians with IV workflow efficiencies and confidence."

Related Links:
BD 

Biopsy Software
Affirm® Contrast
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Portable X-ray Unit
AJEX140H
Ultrasound Table
Women’s Ultrasound EA Table

Channels

Nuclear Medicine

view channel
Image: The new tracer, 64Cu-NOTA-EV-F(ab′)2​, targets nectin-4, a protein strongly linked to tumor growth in both TNBC and UBC cancer types. (Wenpeng Huang et al., DOI: 10.2967/jnumed.125.270132)

PET Tracer Enables Same-Day Imaging of Triple-Negative Breast and Urothelial Cancers

Triple-negative breast cancer (TNBC) and urothelial bladder carcinoma (UBC) are aggressive cancers often diagnosed at advanced stages, leaving limited time for effective treatment decisions.... Read more

General/Advanced Imaging

view channel
Image: Concept of the photo-thermoresponsive SCNPs (J F Thümmler et al., Commun Chem (2025). DOI: 10.1038/s42004-025-01518-x)

New Ultrasmall, Light-Sensitive Nanoparticles Could Serve as Contrast Agents

Medical imaging technologies face ongoing challenges in capturing accurate, detailed views of internal processes, especially in conditions like cancer, where tracking disease development and treatment... Read more

Imaging IT

view channel
Image: The new Medical Imaging Suite makes healthcare imaging data more accessible, interoperable and useful (Photo courtesy of Google Cloud)

New Google Cloud Medical Imaging Suite Makes Imaging Healthcare Data More Accessible

Medical imaging is a critical tool used to diagnose patients, and there are billions of medical images scanned globally each year. Imaging data accounts for about 90% of all healthcare data1 and, until... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.